EUROFINS SCIENT (ERFSF)
(Delayed Data from OTC)
$51.00 USD
-0.11 (-0.21%)
Updated Dec 20, 2024 02:13 PM ET
4-Sell of 5 4
C Value B Growth D Momentum B VGM
EUROFINS SCIENT (ERFSF) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$N/A | $N/A | $N/A | N/A% |
Price Target
EUROFINS SCIENT does not have any price target set by analysts.
Analyst Price Targets ()
Find the top stocks with the greatest price target potential and Zacks Rank of 1 or 2
Broker Rating
EUROFINS SCIENT currently has an average brokerage recommendation (ABR) of 2.29 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 2.29 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, three are Strong Buy, representing 42.86% of all recommendations. A month ago, Strong Buy represented 42.86%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 2 | 2 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.29 | 2.29 | 2.29 | 2.17 | 2.40 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
10/28/2024 | Not Identified | Not Identified | Hold | Hold |
10/7/2024 | Berenberg Bank | Carl Raynsford | Not Available | Strong Buy |
7/18/2024 | Not Identified | Not Identified | Hold | Hold |
6/30/2024 | Goldman Sachs | Suhasini Varanasi | Strong Buy | Strong Buy |
4/22/2024 | Not Identified | Not Identified | Hold | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.29 |
ABR (Last week) | 2.29 |
# of Recs in ABR | 7 |
Average Target Price | NA |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 130 of 251 |
Current Quarter EPS Est: | NA |